More Questions We've Answered Related to This Product
We’ve provided several answers to questions related to Atelvia (Risedronate) Delayed Release , see some other helpful Q&A related to this product.
-
Question: What additional supplements might be necessary when taking this medication?
Answer: It may be necessary to take calcium and vitamin D supplements. These supplements support bone health and enhance the effectiveness of the medication in preventing bone loss.
-
Question: What is the DrugBank ID for this medication?
Answer: The DrugBank ID is DB00884. DrugBank provides comprehensive information about drugs and their mechanisms of action, supporting healthcare providers in making informed decisions.
-
Question: What is the chemical name of this medication?
Answer: The chemical name is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. Understanding the chemical name can provide insight into the molecular structure and function of the drug.
-
Question: What are the brands available for this medication?
Answer: The medication is available under the brands Atelvia and Actonel. Having multiple brand options can offer flexibility in pricing and availability for consumers.
-
Question: What is the elimination half-life of this medication in the bone?
Answer: The elimination half-life in the bone can be up to 10 years. This long half-life in bone tissue helps maintain bone density over time, offering sustained protection against fractures.
